| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.894 | 0 | 0.894 | Anabolic | 0.664 0.001 DB13169 0.446 0.001 DBMET03358 0.347 0.001 DBMET03359 0.446 0.001 DBMET03360 0.212 0.003 DBMET03361 0.2 0.004 DBMET03362 | ||
| 0.85 | 0.005 | 0.85 | Caspase 9 stimulant | 0.771 0.015 DB13169 0.728 0.02 DBMET03358 0.735 0.02 DBMET03359 0.728 0.02 DBMET03360 0.784 0.013 DBMET03361 0.789 0.013 DBMET03362 | ||
| 0.804 | 0.004 | 0.946 | Cholesterol antagonist | 0.708 0.007 DB13169 0.893 0.003 DBMET03358 0.782 0.004 DBMET03359 0.893 0.003 DBMET03360 0.946 0.001 DBMET03361 0.914 0.002 DBMET03362 | DBMET03361 | |
| 0.78 | 0.014 | 0.905 | Transcription factor NF kappa B inhibitor | 0.727 0.018 DB13169 0.717 0.019 DBMET03358 0.68 0.023 DBMET03359 0.717 0.019 DBMET03360 0.905 0.006 DBMET03361 0.885 0.007 DBMET03362 | DBMET03361 | |
| 0.761 | 0.002 | 0.808 | Aromatase inhibitor | 0.808 0.002 DB13169 0.66 0.002 DBMET03358 0.565 0.003 DBMET03359 0.66 0.002 DBMET03360 0.106 0.02 DBMET03361 0.067 0.037 DBMET03362 | DB13169 | |
| 0.699 | 0.001 | 0.848 | Androgen agonist | 0.848 0.001 DB13169 0.612 0.002 DBMET03358 0.521 0.002 DBMET03359 0.612 0.002 DBMET03360 0.194 0.005 DBMET03361 0.167 0.006 DBMET03362 | DB13169 | |
| 0.719 | 0.027 | 0.879 | Antiinflammatory | 0.75 0.022 DB13169 0.749 0.023 DBMET03358 0.803 0.015 DBMET03359 0.749 0.023 DBMET03360 0.858 0.009 DBMET03361 0.879 0.006 DBMET03362 | DBMET03362 | |
| 0.715 | 0.028 | 0.8 | Apoptosis agonist | 0.704 0.03 DB13169 0.725 0.027 DBMET03358 0.784 0.019 DBMET03359 0.725 0.027 DBMET03360 0.77 0.02 DBMET03361 0.8 0.017 DBMET03362 | DBMET03362 | |
| 0.671 | 0.004 | 0.714 | Anesthetic general | 0.707 0.003 DB13169 0.688 0.004 DBMET03358 0.714 0.003 DBMET03359 0.688 0.004 DBMET03360 0.669 0.004 DBMET03361 0.699 0.003 DBMET03362 | DBMET03359 | |
| 0.676 | 0.01 | 0.931 | Aldehyde oxidase inhibitor | 0.931 0.003 DB13169 0.671 0.011 DBMET03358 0.842 0.004 DBMET03359 0.671 0.011 DBMET03360 0.267 0.076 DBMET03362 | DB13169 | |
| 0.648 | 0.003 | 0.834 | Androgen antagonist | 0.834 0.002 DB13169 0.613 0.003 DBMET03358 0.593 0.003 DBMET03359 0.613 0.003 DBMET03360 0.14 0.025 DBMET03361 0.132 0.028 DBMET03362 | DB13169 | |
| 0.636 | 0.003 | 0.776 | Estrogen agonist | 0.776 0.002 DB13169 0.596 0.003 DBMET03358 0.75 0.002 DBMET03359 0.596 0.003 DBMET03360 0.368 0.004 DBMET03361 0.469 0.004 DBMET03362 | DB13169 | |
| 0.606 | 0.008 | 0.606 | DNA damaging | 0.465 0.018 DB13169 0.268 0.071 DBMET03358 0.408 0.027 DBMET03359 0.268 0.071 DBMET03360 0.285 0.064 DBMET03361 0.424 0.024 DBMET03362 | ||
| 0.568 | 0.009 | 0.707 | Hypoxia-inducible factor 1 alpha inhibitor | 0.707 0.004 DB13169 0.556 0.01 DBMET03358 0.498 0.015 DBMET03359 0.556 0.01 DBMET03360 0.585 0.008 DBMET03361 0.529 0.012 DBMET03362 | DB13169 | |
| 0.555 | 0.003 | 0.617 | Lipocortins synthesis antagonist | 0.617 0.002 DB13169 0.549 0.003 DBMET03358 0.581 0.002 DBMET03359 0.549 0.003 DBMET03360 0.442 0.006 DBMET03361 0.456 0.005 DBMET03362 | DB13169 | |
| 0.548 | 0.005 | 0.732 | Diuretic | 0.698 0.004 DB13169 0.559 0.005 DBMET03358 0.482 0.008 DBMET03359 0.559 0.005 DBMET03360 0.732 0.004 DBMET03361 0.677 0.004 DBMET03362 | DBMET03361 | |
| 0.546 | 0.005 | 0.666 | Phospholipase C inhibitor | 0.455 0.008 DB13169 0.612 0.004 DBMET03358 0.666 0.003 DBMET03359 0.612 0.004 DBMET03360 0.38 0.012 DBMET03361 0.456 0.008 DBMET03362 | DBMET03359 | |
| 0.544 | 0.022 | 0.588 | Immunosuppressant | 0.528 0.026 DB13169 0.547 0.021 DBMET03358 0.552 0.02 DBMET03359 0.547 0.021 DBMET03360 0.587 0.015 DBMET03361 0.588 0.015 DBMET03362 | DBMET03362 | |
| 0.524 | 0.017 | 0.655 | Apoptosis antagonist | 0.541 0.015 DB13169 0.506 0.019 DBMET03358 0.631 0.007 DBMET03359 0.506 0.019 DBMET03360 0.612 0.009 DBMET03361 0.655 0.005 DBMET03362 | DBMET03362 | |
| 0.502 | 0.006 | 0.55 | Interferon gamma antagonist | 0.48 0.007 DB13169 0.479 0.007 DBMET03358 0.436 0.009 DBMET03359 0.479 0.007 DBMET03360 0.55 0.004 DBMET03361 0.528 0.005 DBMET03362 | DBMET03361 | |
| 0.497 | 0.005 | 0.497 | Alkylator | 0.377 0.009 DB13169 0.208 0.024 DBMET03358 0.334 0.011 DBMET03359 0.208 0.024 DBMET03360 0.348 0.01 DBMET03361 0.494 0.005 DBMET03362 | ||
| 0.489 | 0.002 | 0.587 | Steroid 17-alpha-hydroxylase/17,20 lyase inhibitor | 0.587 0.002 DB13169 0.346 0.003 DBMET03358 0.425 0.003 DBMET03359 0.346 0.003 DBMET03360 | DB13169 | |
| 0.485 | 0.001 | 0.485 | 5-Alpha-reductase 1 inhibitor | 0.449 0.001 DB13169 0.266 0.002 DBMET03358 0.194 0.003 DBMET03359 0.266 0.002 DBMET03360 0.024 0.01 DBMET03361 | ||
| 0.482 | 0.001 | 0.482 | 5-Alpha-reductase inhibitor | 0.425 0.002 DB13169 0.349 0.002 DBMET03358 0.307 0.003 DBMET03359 0.349 0.002 DBMET03360 0.24 0.004 DBMET03361 0.193 0.005 DBMET03362 | ||
| 0.476 | 0.005 | 0.566 | Sodium/bile acid cotransporter inhibitor | 0.519 0.003 DB13169 0.529 0.003 DBMET03358 0.566 0.002 DBMET03359 0.529 0.003 DBMET03360 0.446 0.008 DBMET03361 0.468 0.005 DBMET03362 | DBMET03359 | |
| 0.477 | 0.01 | 0.477 | P-glycoprotein inhibitor | 0.389 0.017 DB13169 0.296 0.03 DBMET03358 0.472 0.01 DBMET03359 0.296 0.03 DBMET03360 0.236 0.046 DBMET03361 0.313 0.027 DBMET03362 | ||
| 0.473 | 0.018 | 0.678 | Nitric oxide antagonist | 0.562 0.012 DB13169 0.53 0.014 DBMET03358 0.632 0.008 DBMET03359 0.53 0.014 DBMET03360 0.623 0.009 DBMET03361 0.678 0.006 DBMET03362 | DBMET03362 | |
| 0.442 | 0.004 | 0.729 | Estrogen antagonist | 0.729 0.003 DB13169 0.419 0.004 DBMET03358 0.663 0.003 DBMET03359 0.419 0.004 DBMET03360 0.171 0.017 DBMET03361 0.248 0.009 DBMET03362 | DB13169 | |
| 0.442 | 0.006 | 0.652 | NOS3 expression enhancer | 0.652 0.004 DB13169 0.353 0.011 DBMET03358 0.633 0.004 DBMET03359 0.353 0.011 DBMET03360 0.381 0.009 DBMET03361 0.558 0.004 DBMET03362 | DB13169 | |
| 0.434 | 0.018 | 0.494 | Psychostimulant | 0.266 0.053 DB13169 0.494 0.011 DBMET03358 0.296 0.044 DBMET03359 0.494 0.011 DBMET03360 0.462 0.015 DBMET03361 0.261 0.055 DBMET03362 | DBMET03360 | |
| 0.416 | 0.001 | 0.429 | 5-Alpha-reductase 2 inhibitor | 0.429 0.001 DB13169 0.309 0.002 DBMET03358 0.237 0.003 DBMET03359 0.309 0.002 DBMET03360 0.129 0.004 DBMET03361 0.07 0.006 DBMET03362 | DB13169 | |
| 0.398 | 0.008 | 0.467 | Protein kinase stimulant | 0.239 0.029 DB13169 0.38 0.009 DBMET03358 0.236 0.03 DBMET03359 0.38 0.009 DBMET03360 0.467 0.005 DBMET03361 0.319 0.014 DBMET03362 | DBMET03361 | |
| 0.406 | 0.018 | 0.772 | Interleukin agonist | 0.338 0.032 DB13169 0.584 0.005 DBMET03358 0.432 0.015 DBMET03359 0.584 0.005 DBMET03360 0.772 0.003 DBMET03361 0.592 0.005 DBMET03362 | DBMET03361 | |
| 0.411 | 0.024 | 0.619 | Interleukin 2 agonist | 0.425 0.021 DB13169 0.619 0.003 DBMET03358 0.488 0.009 DBMET03359 0.619 0.003 DBMET03360 0.592 0.004 DBMET03361 0.505 0.007 DBMET03362 | DBMET03360 | |
| 0.381 | 0.005 | 0.506 | Cholesterol synthesis inhibitor | 0.343 0.008 DB13169 0.506 0.002 DBMET03358 0.431 0.004 DBMET03359 0.506 0.002 DBMET03360 0.415 0.004 DBMET03361 0.337 0.008 DBMET03362 | DBMET03360 | |
| 0.363 | 0.002 | 0.611 | Aldosterone antagonist | 0.611 0.001 DB13169 0.241 0.003 DBMET03358 0.295 0.003 DBMET03359 0.241 0.003 DBMET03360 | DB13169 | |
| 0.405 | 0.048 | 0.631 | Immunostimulant | 0.347 0.065 DB13169 0.425 0.043 DBMET03358 0.424 0.043 DBMET03359 0.425 0.043 DBMET03360 0.631 0.013 DBMET03361 0.631 0.013 DBMET03362 | DBMET03362 | |
| 0.374 | 0.025 | 0.55 | DNA synthesis inhibitor | 0.362 0.028 DB13169 0.398 0.022 DBMET03358 0.442 0.018 DBMET03359 0.398 0.022 DBMET03360 0.515 0.012 DBMET03361 0.55 0.01 DBMET03362 | DBMET03362 | |
| 0.365 | 0.016 | 0.527 | Platelet adhesion inhibitor | 0.235 0.055 DB13169 0.321 0.027 DBMET03358 0.405 0.011 DBMET03359 0.321 0.027 DBMET03360 0.485 0.005 DBMET03361 0.527 0.005 DBMET03362 | DBMET03362 | |
| 0.36 | 0.012 | 0.36 | Bone formation stimulant | 0.344 0.013 DB13169 0.323 0.015 DBMET03358 0.337 0.014 DBMET03359 0.323 0.015 DBMET03360 0.216 0.032 DBMET03361 0.21 0.033 DBMET03362 | ||
| 0.349 | 0.003 | 0.572 | Progesterone antagonist | 0.572 0.002 DB13169 0.285 0.004 DBMET03358 0.269 0.004 DBMET03359 0.285 0.004 DBMET03360 | DB13169 | |
| 0.369 | 0.028 | 0.804 | Angiogenesis stimulant | 0.323 0.041 DB13169 0.345 0.034 DBMET03358 0.373 0.027 DBMET03359 0.345 0.034 DBMET03360 0.77 0.004 DBMET03361 0.804 0.004 DBMET03362 | DBMET03362 | |
| 0.376 | 0.04 | 0.67 | Antioxidant | 0.409 0.033 DB13169 0.368 0.042 DBMET03358 0.454 0.026 DBMET03359 0.368 0.042 DBMET03360 0.628 0.009 DBMET03361 0.67 0.007 DBMET03362 | DBMET03362 | |
| 0.353 | 0.019 | 0.649 | Hepatoprotectant | 0.359 0.018 DB13169 0.411 0.012 DBMET03358 0.503 0.007 DBMET03359 0.411 0.012 DBMET03360 0.592 0.005 DBMET03361 0.649 0.004 DBMET03362 | DBMET03362 | |
| 0.324 | 0.002 | 0.534 | RNA-directed RNA polymerase stimulant | 0.485 0.001 DB13169 0.456 0.001 DBMET03358 0.534 0.001 DBMET03359 0.456 0.001 DBMET03360 0.23 0.003 DBMET03361 0.278 0.002 DBMET03362 | DBMET03359 | |
| 0.366 | 0.048 | 0.366 | Spasmolytic | 0.167 0.147 DB13169 0.194 0.125 DBMET03358 0.219 0.106 DBMET03359 0.194 0.125 DBMET03360 0.317 0.064 DBMET03361 0.354 0.051 DBMET03362 | ||
| 0.316 | 0.004 | 0.501 | Mineralocorticoid receptor antagonist | 0.501 0.003 DB13169 0.115 0.006 DBMET03358 0.127 0.005 DBMET03359 0.115 0.006 DBMET03360 | DB13169 | |
| 0.312 | 0.001 | 0.312 | Arachidonic acid antagonist | 0.303 0.002 DB13169 0.29 0.002 DBMET03358 0.279 0.003 DBMET03359 0.29 0.002 DBMET03360 0.239 0.008 DBMET03361 0.228 0.013 DBMET03362 | ||
| 0.311 | 0.003 | 0.661 | Estradiol 17 beta-dehydrogenase inhibitor | 0.661 0.002 DB13169 0.491 0.002 DBMET03358 0.33 0.003 DBMET03359 0.491 0.002 DBMET03360 0.039 0.032 DBMET03361 | DB13169 | |
| 0.312 | 0.005 | 0.657 | Estrogen receptor alpha antagonist | 0.657 0.003 DB13169 0.41 0.004 DBMET03358 0.388 0.004 DBMET03359 0.41 0.004 DBMET03360 | DB13169 | |
| 0.342 | 0.037 | 0.494 | Hypolipemic | 0.236 0.074 DB13169 0.415 0.023 DBMET03358 0.494 0.013 DBMET03359 0.415 0.023 DBMET03360 0.407 0.024 DBMET03361 0.448 0.018 DBMET03362 | DBMET03359 | |
| 0.387 | 0.083 | 0.643 | Antibacterial | 0.303 0.133 DB13169 0.343 0.106 DBMET03358 0.346 0.104 DBMET03359 0.343 0.106 DBMET03360 0.642 0.014 DBMET03361 0.643 0.014 DBMET03362 | DBMET03362 | |
| 0.357 | 0.055 | 0.427 | 5 Hydroxytryptamine release stimulant | 0.324 0.063 DB13169 0.338 0.059 DBMET03358 0.421 0.042 DBMET03359 0.338 0.059 DBMET03360 0.376 0.051 DBMET03361 0.427 0.04 DBMET03362 | DBMET03362 | |
| 0.32 | 0.021 | 0.32 | Gastrin inhibitor | 0.237 0.095 DB13169 0.285 0.044 DBMET03358 0.266 0.061 DBMET03359 0.285 0.044 DBMET03360 0.251 0.078 DBMET03361 0.231 0.103 DBMET03362 | ||
| 0.312 | 0.015 | 0.512 | Neurotrophic factor enhancer | 0.338 0.011 DB13169 0.512 0.004 DBMET03358 0.393 0.006 DBMET03359 0.512 0.004 DBMET03360 0.392 0.006 DBMET03361 0.311 0.015 DBMET03362 | DBMET03360 | |
| 0.316 | 0.02 | 0.519 | Melanin inhibitor | 0.307 0.021 DB13169 0.335 0.018 DBMET03358 0.184 0.049 DBMET03359 0.335 0.018 DBMET03360 0.519 0.006 DBMET03361 0.326 0.019 DBMET03362 | DBMET03361 | |
| 0.353 | 0.058 | 0.496 | Caspase 3 stimulant | 0.451 0.029 DB13169 0.437 0.033 DBMET03358 0.496 0.021 DBMET03359 0.437 0.033 DBMET03360 0.449 0.03 DBMET03361 0.481 0.023 DBMET03362 | DBMET03359 | |
| 0.353 | 0.072 | 0.476 | Vasodilator, peripheral | 0.288 0.103 DB13169 0.415 0.051 DBMET03358 0.476 0.033 DBMET03359 0.415 0.051 DBMET03360 0.414 0.051 DBMET03361 0.473 0.034 DBMET03362 | DBMET03359 | |
| 0.285 | 0.007 | 0.424 | Farnesoid X receptor antagonist | 0.341 0.004 DB13169 0.332 0.005 DBMET03358 0.424 0.003 DBMET03359 0.332 0.005 DBMET03360 0.179 0.029 DBMET03361 0.252 0.011 DBMET03362 | DBMET03359 | |
| 0.287 | 0.015 | 0.406 | Adenylate cyclase inhibitor | 0.406 0.007 DB13169 0.237 0.02 DBMET03358 0.339 0.01 DBMET03359 0.237 0.02 DBMET03360 0.147 0.047 DBMET03361 0.252 0.019 DBMET03362 | DB13169 | |
| 0.313 | 0.049 | 0.578 | Tumour necrosis factor alpha release inhibitor | 0.251 0.075 DB13169 0.314 0.048 DBMET03358 0.382 0.03 DBMET03359 0.314 0.048 DBMET03360 0.53 0.012 DBMET03361 0.578 0.009 DBMET03362 | DBMET03362 | |
| 0.281 | 0.022 | 0.349 | Lipid peroxidase inhibitor | 0.293 0.02 DB13169 0.142 0.074 DBMET03358 0.216 0.035 DBMET03359 0.142 0.074 DBMET03360 0.292 0.02 DBMET03361 0.349 0.013 DBMET03362 | DBMET03362 | |
| 0.287 | 0.028 | 0.339 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.339 0.014 DB13169 0.289 0.027 DBMET03358 0.261 0.038 DBMET03359 0.289 0.027 DBMET03360 0.169 0.109 DBMET03361 0.154 0.139 DBMET03362 | DB13169 | |
| 0.261 | 0.002 | 0.364 | Glycine receptor antagonist | 0.224 0.003 DB13169 0.322 0.002 DBMET03358 0.227 0.003 DBMET03359 0.322 0.002 DBMET03360 0.364 0.002 DBMET03361 0.257 0.003 DBMET03362 | DBMET03361 | |
| 0.263 | 0.005 | 0.274 | Microtubule formation inhibitor | 0.262 0.005 DB13169 0.268 0.005 DBMET03358 0.27 0.004 DBMET03359 0.268 0.005 DBMET03360 0.272 0.004 DBMET03361 0.274 0.004 DBMET03362 | DBMET03362 | |
| 0.275 | 0.019 | 0.275 | Antipruritic | 0.229 0.033 DB13169 0.275 0.019 DBMET03358 0.218 0.038 DBMET03359 0.275 0.019 DBMET03360 0.153 0.091 DBMET03361 | ||
| 0.257 | 0.004 | 0.543 | Estrogen receptor alpha agonist | 0.509 0.002 DB13169 0.339 0.003 DBMET03358 0.543 0.002 DBMET03359 0.339 0.003 DBMET03360 0.098 0.009 DBMET03361 0.188 0.005 DBMET03362 | DBMET03359 | |
| 0.256 | 0.005 | 0.405 | Pregnane X receptor agonist | 0.405 0.003 DB13169 0.27 0.004 DBMET03358 0.391 0.003 DBMET03359 0.27 0.004 DBMET03360 | DB13169 | |
| 0.294 | 0.045 | 0.418 | Antimitotic | 0.367 0.029 DB13169 0.181 0.095 DBMET03358 0.418 0.021 DBMET03359 0.181 0.095 DBMET03360 0.21 0.078 DBMET03362 | DBMET03359 | |
| 0.247 | 0.004 | 0.34 | Bile acid receptor antagonist | 0.281 0.003 DB13169 0.215 0.004 DBMET03358 0.34 0.003 DBMET03359 0.215 0.004 DBMET03360 0.119 0.02 DBMET03361 0.16 0.006 DBMET03362 | DBMET03359 | |
| 0.242 | 0.002 | 0.332 | Progesterone agonist | 0.332 0.001 DB13169 0.121 0.003 DBMET03358 0.126 0.003 DBMET03359 0.121 0.003 DBMET03360 0.034 0.006 DBMET03361 0.031 0.007 DBMET03362 | DB13169 | |
| 0.289 | 0.051 | 0.289 | 5 Hydroxytryptamine uptake stimulant | 0.245 0.086 DB13169 0.257 0.074 DBMET03358 0.279 0.057 DBMET03359 0.257 0.074 DBMET03360 | ||
| 0.24 | 0.004 | 0.527 | Estrogen receptor beta agonist | 0.522 0.003 DB13169 0.339 0.004 DBMET03358 0.527 0.003 DBMET03359 0.339 0.004 DBMET03360 0.165 0.006 DBMET03361 0.217 0.004 DBMET03362 | DBMET03359 | |
| 0.239 | 0.007 | 0.497 | Estrogen receptor beta antagonist | 0.497 0.004 DB13169 0.311 0.005 DBMET03358 0.473 0.004 DBMET03359 0.311 0.005 DBMET03360 0.107 0.051 DBMET03361 0.121 0.031 DBMET03362 | DB13169 | |
| 0.232 | 0.005 | 0.28 | Adenylate cyclase stimulant | 0.253 0.004 DB13169 0.25 0.004 DBMET03358 0.28 0.003 DBMET03359 0.25 0.004 DBMET03360 0.188 0.02 DBMET03361 0.209 0.01 DBMET03362 | DBMET03359 | |
| 0.309 | 0.082 | 0.752 | Antithrombotic | 0.239 0.135 DB13169 0.342 0.067 DBMET03358 0.387 0.053 DBMET03359 0.342 0.067 DBMET03360 0.719 0.007 DBMET03361 0.752 0.005 DBMET03362 | DBMET03362 | |
| 0.246 | 0.024 | 0.332 | Interleukin 6 antagonist | 0.202 0.04 DB13169 0.191 0.046 DBMET03358 0.203 0.039 DBMET03359 0.191 0.046 DBMET03360 0.317 0.013 DBMET03361 0.332 0.011 DBMET03362 | DBMET03362 | |
| 0.214 | 0.004 | 0.286 | Glycine receptor agonist | 0.228 0.004 DB13169 0.249 0.003 DBMET03358 0.286 0.002 DBMET03359 0.249 0.003 DBMET03360 0.2 0.004 DBMET03361 0.243 0.003 DBMET03362 | DBMET03359 | |
| 0.251 | 0.043 | 0.331 | Growth hormone agonist | 0.277 0.037 DB13169 0.154 0.084 DBMET03358 0.331 0.027 DBMET03359 0.154 0.084 DBMET03360 | DBMET03359 | |
| 0.216 | 0.023 | 0.266 | DNA polymerase I inhibitor | 0.211 0.025 DB13169 0.264 0.015 DBMET03358 0.266 0.015 DBMET03359 0.264 0.015 DBMET03360 0.237 0.019 DBMET03361 0.234 0.02 DBMET03362 | DBMET03359 | |
| 0.197 | 0.009 | 0.197 | Prolactin inhibitor | 0.14 0.027 DB13169 0.133 0.03 DBMET03358 0.173 0.014 DBMET03359 0.133 0.03 DBMET03360 | ||
| 0.189 | 0.004 | 0.3 | Glucocorticoid antagonist | 0.3 0.003 DB13169 0.128 0.004 DBMET03358 0.16 0.004 DBMET03359 0.128 0.004 DBMET03360 0.06 0.011 DBMET03361 0.06 0.011 DBMET03362 | DB13169 | |
| 0.217 | 0.032 | 0.324 | Tubulin antagonist | 0.324 0.017 DB13169 0.233 0.028 DBMET03359 | DB13169 | |
| 0.185 | 0.009 | 0.185 | Toll-Like receptor 4 antagonist | 0.105 0.062 DB13169 0.143 0.025 DBMET03358 0.115 0.049 DBMET03359 0.143 0.025 DBMET03360 0.174 0.011 DBMET03361 0.166 0.014 DBMET03362 | ||
| 0.18 | 0.007 | 0.18 | Ca2+-transporting ATPase inhibitor | 0.153 0.036 DB13169 0.163 0.019 DBMET03358 0.171 0.012 DBMET03359 0.163 0.019 DBMET03360 0.16 0.023 DBMET03361 0.168 0.015 DBMET03362 | ||
| 0.192 | 0.022 | 0.324 | Cyclooxygenase 3 inhibitor | 0.152 0.047 DB13169 0.135 0.062 DBMET03358 0.144 0.053 DBMET03359 0.135 0.062 DBMET03360 0.295 0.006 DBMET03361 0.324 0.005 DBMET03362 | DBMET03362 | |
| 0.177 | 0.009 | 0.386 | Beta tubulin antagonist | 0.386 0.004 DB13169 0.078 0.03 DBMET03358 0.317 0.005 DBMET03359 0.078 0.03 DBMET03360 0.05 0.046 DBMET03362 | DB13169 | |
| 0.179 | 0.015 | 0.179 | Acetylcholine nicotinic antagonist | 0.119 0.03 DB13169 0.094 0.043 DBMET03358 0.162 0.018 DBMET03359 0.094 0.043 DBMET03360 | ||
| 0.164 | 0.003 | 0.186 | Estrone sulfatase inhibitor | 0.181 0.002 DB13169 0.186 0.002 DBMET03358 0.168 0.003 DBMET03359 0.186 0.002 DBMET03360 0.099 0.005 DBMET03361 0.046 0.008 DBMET03362 | DBMET03360 | |
| 0.169 | 0.012 | 0.313 | Keratolytic | 0.313 0.004 DB13169 0.278 0.004 DBMET03358 0.282 0.004 DBMET03359 0.278 0.004 DBMET03360 0.073 0.06 DBMET03361 0.076 0.055 DBMET03362 | DB13169 | |
| 0.154 | 0.009 | 0.362 | Alpha tubulin antagonist | 0.354 0.004 DB13169 0.07 0.024 DBMET03358 0.362 0.004 DBMET03359 0.07 0.024 DBMET03360 0.062 0.029 DBMET03362 | DBMET03359 | |
| 0.154 | 0.01 | 0.154 | Ornithine decarboxylase inhibitor | 0.13 0.019 DB13169 0.107 0.037 DBMET03358 0.106 0.038 DBMET03359 0.107 0.037 DBMET03360 0.078 0.07 DBMET03361 0.078 0.069 DBMET03362 | ||
| 0.144 | 0.004 | 0.516 | Estradiol 17 beta-dehydrogenase 3 inhibitor | 0.434 0.002 DB13169 0.516 0.001 DBMET03358 0.31 0.002 DBMET03359 0.516 0.001 DBMET03360 0.041 0.015 DBMET03361 | DBMET03360 | |
| 0.217 | 0.077 | 0.282 | RNA-directed DNA polymerase inhibitor | 0.26 0.044 DB13169 0.282 0.036 DBMET03358 0.257 0.045 DBMET03359 0.282 0.036 DBMET03360 0.266 0.041 DBMET03361 0.245 0.053 DBMET03362 | DBMET03360 | |
| 0.146 | 0.007 | 0.349 | Na+ K+ transporting ATPase inhibitor | 0.172 0.003 DB13169 0.227 0.002 DBMET03358 0.211 0.002 DBMET03359 0.227 0.002 DBMET03360 0.349 0.001 DBMET03361 0.308 0.001 DBMET03362 | DBMET03361 | |
| 0.171 | 0.037 | 0.22 | Aldehyde dehydrogenase inhibitor | 0.22 0.023 DB13169 0.178 0.034 DBMET03358 0.189 0.03 DBMET03359 0.178 0.034 DBMET03360 0.134 0.058 DBMET03361 0.149 0.048 DBMET03362 | DB13169 | |
| 0.215 | 0.086 | 0.519 | Free radical scavenger | 0.213 0.087 DB13169 0.199 0.099 DBMET03358 0.203 0.096 DBMET03359 0.199 0.099 DBMET03360 0.501 0.016 DBMET03361 0.519 0.014 DBMET03362 | DBMET03362 | |
| 0.171 | 0.042 | 0.201 | Cholinergic antagonist | 0.13 0.065 DB13169 0.142 0.057 DBMET03358 0.201 0.032 DBMET03359 0.142 0.057 DBMET03360 | DBMET03359 | |
| 0.134 | 0.006 | 0.196 | Estrogen-related receptor beta agonist | 0.196 0.003 DB13169 0.128 0.007 DBMET03358 0.182 0.003 DBMET03359 0.128 0.007 DBMET03360 0.085 0.053 DBMET03362 | DB13169 | |
| 0.165 | 0.043 | 0.198 | Acetylcholine antagonist | 0.127 0.064 DB13169 0.14 0.056 DBMET03358 0.198 0.031 DBMET03359 0.14 0.056 DBMET03360 | DBMET03359 | |
| 0.148 | 0.028 | 0.168 | Antineoplastic alkaloid | 0.126 0.035 DB13169 0.168 0.023 DBMET03358 0.164 0.024 DBMET03359 0.168 0.023 DBMET03360 | DBMET03360 | |
| 0.126 | 0.007 | 0.348 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | 0.348 0.002 DB13169 0.307 0.002 DBMET03358 0.26 0.003 DBMET03359 0.307 0.002 DBMET03360 0.069 0.022 DBMET03361 0.051 0.041 DBMET03362 | DB13169 | |
| 0.15 | 0.031 | 0.15 | Photosensitizer | 0.1 0.088 DBMET03359 0.126 0.05 DBMET03361 0.134 0.043 DBMET03362 | ||
| 0.119 | 0.003 | 0.124 | Lipocortins synthesis agonist | 0.124 0.003 DB13169 0.123 0.003 DBMET03358 0.123 0.003 DBMET03359 0.123 0.003 DBMET03360 0.109 0.004 DBMET03361 0.107 0.004 DBMET03362 | DB13169 | |
| 0.158 | 0.044 | 0.282 | Monophenol monooxygenase inhibitor | 0.135 0.053 DB13169 0.113 0.066 DBMET03358 0.087 0.085 DBMET03359 0.113 0.066 DBMET03360 0.282 0.02 DBMET03361 0.234 0.026 DBMET03362 | DBMET03361 | |
| 0.127 | 0.022 | 0.136 | Inducible nitric-oxide synthase inhibitor | 0.136 0.019 DB13169 0.087 0.051 DBMET03358 0.101 0.036 DBMET03359 0.087 0.051 DBMET03360 | DB13169 | |
| 0.127 | 0.026 | 0.127 | Thioredoxin inhibitor | |||
| 0.214 | 0.117 | 0.311 | Transcription factor STAT3 inhibitor | 0.27 0.069 DB13169 0.262 0.075 DBMET03358 0.311 0.048 DBMET03359 0.262 0.075 DBMET03360 0.185 0.156 DBMET03361 0.224 0.107 DBMET03362 | DBMET03359 | |
| 0.096 | 0.004 | 0.11 | Pregnane X receptor antagonist | 0.098 0.004 DB13169 0.11 0.003 DBMET03358 0.097 0.004 DBMET03359 0.11 0.003 DBMET03360 | DBMET03360 | |
| 0.113 | 0.021 | 0.231 | CDC25A inhibitor | 0.116 0.02 DB13169 0.231 0.005 DBMET03358 0.16 0.011 DBMET03359 0.231 0.005 DBMET03360 0.126 0.017 DBMET03361 0.078 0.046 DBMET03362 | DBMET03360 | |
| 0.093 | 0.009 | 0.105 | Potassium channel Kv1.3 blocker | 0.093 0.009 DB13169 0.105 0.007 DBMET03358 0.086 0.01 DBMET03359 0.105 0.007 DBMET03360 | DBMET03360 | |
| 0.179 | 0.096 | 0.179 | Insulin sensitizer | 0.175 0.101 DBMET03358 0.151 0.132 DBMET03359 0.175 0.101 DBMET03360 | ||
| 0.12 | 0.038 | 0.299 | Antineoplastic antibiotic | 0.145 0.032 DB13169 0.167 0.027 DBMET03358 0.169 0.027 DBMET03359 0.167 0.027 DBMET03360 0.29 0.01 DBMET03361 0.299 0.01 DBMET03362 | DBMET03362 | |
| 0.137 | 0.055 | 0.219 | Anesthetic local | 0.219 0.027 DBMET03358 0.194 0.034 DBMET03359 0.219 0.027 DBMET03360 | DBMET03360 | |
| 0.125 | 0.044 | 0.513 | AMP-activated protein kinase stimulant | 0.163 0.021 DB13169 0.159 0.023 DBMET03358 0.193 0.012 DBMET03359 0.159 0.023 DBMET03360 0.432 0.004 DBMET03361 0.513 0.003 DBMET03362 | DBMET03362 | |
| 0.136 | 0.055 | 0.136 | Vanilloid 1 agonist | 0.114 0.103 DBMET03359 0.115 0.1 DBMET03362 | ||
| 0.129 | 0.056 | 0.144 | Protein-tyrosine phosphatase 1B inhibitor | 0.123 0.061 DB13169 0.112 0.069 DBMET03358 0.117 0.065 DBMET03359 0.112 0.069 DBMET03360 0.139 0.05 DBMET03361 0.144 0.048 DBMET03362 | DBMET03362 | |
| 0.077 | 0.005 | 0.203 | 11-Beta-hydroxysteroid dehydrogenase 2 inhibitor | 0.184 0.003 DB13169 0.198 0.003 DBMET03358 0.203 0.003 DBMET03359 0.198 0.003 DBMET03360 0.187 0.003 DBMET03361 0.189 0.003 DBMET03362 | DBMET03359 | |
| 0.087 | 0.016 | 0.087 | Nitric oxide donor | 0.067 0.037 DBMET03359 0.07 0.032 DBMET03361 0.08 0.022 DBMET03362 | ||
| 0.073 | 0.005 | 0.314 | Estradiol 17 beta-dehydrogenase 1 inhibitor | 0.314 0.002 DB13169 0.231 0.002 DBMET03358 0.144 0.003 DBMET03359 0.231 0.002 DBMET03360 | DB13169 | |
| 0.07 | 0.005 | 0.7 | Glucose-6-phosphate dehydrogenase inhibitor | 0.094 0.003 DB13169 0.7 0.001 DBMET03358 0.172 0.002 DBMET03359 0.7 0.001 DBMET03360 0.115 0.003 DBMET03361 0.066 0.005 DBMET03362 | DBMET03360 | |
| 0.08 | 0.015 | 0.102 | Heme oxygenase stimulant | 0.1 0.007 DB13169 0.1 0.007 DBMET03358 0.102 0.007 DBMET03359 0.1 0.007 DBMET03360 0.075 0.02 DBMET03361 0.073 0.021 DBMET03362 | DBMET03359 | |
| 0.101 | 0.038 | 0.237 | Transcription factor NF kappa B stimulant | 0.117 0.027 DB13169 0.123 0.024 DBMET03358 0.161 0.014 DBMET03359 0.123 0.024 DBMET03360 0.202 0.009 DBMET03361 0.237 0.006 DBMET03362 | DBMET03362 | |
| 0.143 | 0.082 | 0.143 | Phospholipase A2 inhibitor | |||
| 0.186 | 0.127 | 0.651 | Hypoglycemic | 0.171 0.146 DB13169 0.188 0.125 DBMET03358 0.267 0.067 DBMET03359 0.188 0.125 DBMET03360 0.598 0.008 DBMET03361 0.651 0.006 DBMET03362 | DBMET03362 | |
| 0.067 | 0.008 | 0.086 | Microtubule stabilization | 0.069 0.007 DB13169 0.066 0.009 DBMET03358 0.086 0.004 DBMET03359 0.066 0.009 DBMET03360 0.063 0.011 DBMET03361 0.073 0.005 DBMET03362 | DBMET03359 | |
| 0.072 | 0.015 | 0.093 | Acetyl-CoA transferase 2 inhibitor | 0.08 0.01 DBMET03358 0.093 0.007 DBMET03359 0.08 0.01 DBMET03360 0.054 0.045 DBMET03362 | DBMET03359 | |
| 0.062 | 0.009 | 0.155 | Farnesoid X receptor agonist | 0.088 0.005 DB13169 0.126 0.003 DBMET03358 0.155 0.003 DBMET03359 0.126 0.003 DBMET03360 0.037 0.027 DBMET03362 | DBMET03359 | |
| 0.163 | 0.114 | 0.287 | Growth factor agonist | 0.239 0.036 DB13169 0.287 0.018 DBMET03358 0.276 0.022 DBMET03359 0.287 0.018 DBMET03360 0.192 0.071 DBMET03361 0.177 0.091 DBMET03362 | DBMET03360 | |
| 0.052 | 0.003 | 0.06 | Corticosteroid-like | 0.06 0.003 DB13169 0.051 0.003 DBMET03358 0.049 0.003 DBMET03359 0.051 0.003 DBMET03360 0.039 0.004 DBMET03361 0.037 0.004 DBMET03362 | DB13169 | |
| 0.053 | 0.004 | 0.066 | Glucocorticoid agonist | 0.066 0.003 DB13169 0.056 0.004 DBMET03358 0.061 0.004 DBMET03359 0.056 0.004 DBMET03360 0.011 0.01 DBMET03361 0.012 0.01 DBMET03362 | DB13169 | |
| 0.129 | 0.082 | 0.361 | Neurotrophic factor | 0.143 0.065 DB13169 0.361 0.005 DBMET03358 0.272 0.009 DBMET03359 0.361 0.005 DBMET03360 0.222 0.019 DBMET03361 0.18 0.038 DBMET03362 | DBMET03360 | |
| 0.104 | 0.059 | 0.127 | Bronchodilator | 0.092 0.072 DB13169 0.12 0.044 DBMET03358 0.127 0.041 DBMET03359 0.12 0.044 DBMET03360 | DBMET03359 | |
| 0.123 | 0.079 | 0.506 | Amylase inhibitor | 0.235 0.032 DB13169 0.222 0.037 DBMET03358 0.291 0.019 DBMET03359 0.222 0.037 DBMET03360 0.388 0.01 DBMET03361 0.506 0.005 DBMET03362 | DBMET03362 | |
| 0.047 | 0.003 | 0.109 | Hedgehog signaling activator | 0.048 0.003 DB13169 0.086 0.002 DBMET03358 0.109 0.001 DBMET03359 0.086 0.002 DBMET03360 0.029 0.016 DBMET03362 | DBMET03359 | |
| 0.049 | 0.008 | 0.049 | ATP citrate lysase inhibitor | 0.031 0.024 DB13169 | ||
| 0.152 | 0.112 | 0.313 | Non-steroidal antiinflammatory agent | 0.142 0.127 DBMET03358 0.142 0.127 DBMET03360 0.313 0.025 DBMET03361 0.297 0.029 DBMET03362 | DBMET03361 | |
| 0.1 | 0.064 | 0.175 | Hedgehog signaling inhibitor | 0.16 0.02 DB13169 0.111 0.048 DBMET03358 0.175 0.016 DBMET03359 0.111 0.048 DBMET03360 | DBMET03359 | |
| 0.132 | 0.099 | 0.139 | Protein-tyrosine phosphatase inhibitor | 0.123 0.11 DB13169 0.137 0.093 DBMET03361 0.139 0.091 DBMET03362 | DBMET03362 | |
| 0.092 | 0.062 | 0.152 | ABCA1 expression enhancer | 0.097 0.055 DB13169 0.134 0.023 DBMET03358 0.152 0.017 DBMET03359 0.134 0.023 DBMET03360 | DBMET03359 | |
| 0.042 | 0.013 | 0.068 | HMG CoA reductase inhibitor | 0.038 0.017 DB13169 0.055 0.005 DBMET03358 0.068 0.004 DBMET03359 0.055 0.005 DBMET03360 0.035 0.023 DBMET03362 | DBMET03359 | |
| 0.032 | 0.004 | 0.049 | Vitamin D receptor agonist | 0.025 0.004 DB13169 0.041 0.003 DBMET03358 0.049 0.003 DBMET03359 0.041 0.003 DBMET03360 0.021 0.006 DBMET03361 0.022 0.005 DBMET03362 | DBMET03359 | |
| 0.05 | 0.026 | 0.116 | Adenylate cyclase 1 inhibitor | 0.114 0.003 DB13169 0.1 0.004 DBMET03358 0.116 0.003 DBMET03359 0.1 0.004 DBMET03360 | DBMET03359 | |
| 0.082 | 0.059 | 0.082 | T cell inhibitor | 0.082 0.059 DB13169 | ||
| 0.214 | 0.192 | 0.414 | Calcium channel activator | 0.346 0.053 DB13169 0.347 0.052 DBMET03358 0.414 0.02 DBMET03359 0.347 0.052 DBMET03360 | DBMET03359 | |
| 0.022 | 0.003 | 0.028 | 3 Beta-hydroxy-delta 5-steroid dehydrogenase inhibitor | 0.028 0.002 DB13169 0.023 0.002 DBMET03358 0.022 0.003 DBMET03359 0.023 0.002 DBMET03360 0.014 0.005 DBMET03361 0.013 0.008 DBMET03362 | DB13169 | |
| 0.021 | 0.001 | 0.457 | Transcortin receptor antagonist | 0.457 0 DB13169 0.178 0 DBMET03358 0.077 0 DBMET03359 0.178 0 DBMET03360 0.009 0.003 DBMET03361 0.006 0.004 DBMET03362 | DB13169 | |
| 0.123 | 0.106 | 0.324 | Thrombolytic | 0.288 0.026 DBMET03361 0.324 0.02 DBMET03362 | DBMET03362 | |
| 0.021 | 0.006 | 0.072 | Telomerase stimulant | 0.035 0.002 DB13169 0.045 0.002 DBMET03358 0.051 0.001 DBMET03359 0.045 0.002 DBMET03360 0.065 0.001 DBMET03361 0.072 0.001 DBMET03362 | DBMET03362 | |
| 0.052 | 0.038 | 0.152 | Protein 50S ribosomal subunit inhibitor | 0.065 0.027 DBMET03358 0.061 0.03 DBMET03359 0.065 0.027 DBMET03360 0.147 0.007 DBMET03361 0.152 0.006 DBMET03362 | DBMET03362 | |
| 0.028 | 0.015 | 0.038 | Toll-Like receptor 4 agonist | 0.036 0.007 DBMET03361 0.038 0.005 DBMET03362 | DBMET03362 | |
| 0.18 | 0.167 | 0.296 | Transcription factor STAT inhibitor | 0.274 0.071 DB13169 0.245 0.09 DBMET03358 0.296 0.058 DBMET03359 0.245 0.09 DBMET03360 | DBMET03359 | |
| 0.021 | 0.008 | 0.087 | Ileal bile acid transport inhibitor | 0.031 0.005 DB13169 0.056 0.003 DBMET03358 0.087 0.002 DBMET03359 0.056 0.003 DBMET03360 0.058 0.003 DBMET03361 0.087 0.002 DBMET03362 | DBMET03362 | |
| 0.103 | 0.09 | 0.14 | Interleukin 8 antagonist | 0.14 0.041 DB13169 0.122 0.059 DBMET03358 0.114 0.069 DBMET03359 0.122 0.059 DBMET03360 | DB13169 | |
| 0.038 | 0.027 | 0.041 | Vanilloid 3 antagonist | 0.041 0.02 DBMET03358 0.038 0.026 DBMET03359 0.041 0.02 DBMET03360 | DBMET03360 | |
| 0.024 | 0.014 | 0.026 | Prostaglandin F2 alpha agonist | 0.026 0.011 DBMET03358 0.023 0.015 DBMET03359 0.026 0.011 DBMET03360 | DBMET03360 | |
| 0.023 | 0.014 | 0.055 | Vitamin D receptor antagonist | 0.025 0.01 DB13169 0.04 0.005 DBMET03358 0.055 0.004 DBMET03359 0.04 0.005 DBMET03360 0.023 0.013 DBMET03361 0.024 0.011 DBMET03362 | DBMET03359 | |
| 0.05 | 0.041 | 0.05 | Acetyl-CoA transferase inhibitor | |||
| 0.029 | 0.026 | 0.029 | Elastase 3A inhibitor | |||
| 0.029 | 0.026 | 0.029 | Elastase 3B inhibitor | |||
| 0.029 | 0.026 | 0.029 | Elastase 2B inhibitor | |||
| 0.018 | 0.015 | 0.027 | Progesterone receptor B antagonist | 0.027 0.006 DB13169 | DB13169 | |
| 0.008 | 0.009 | 0.03 | Progesterone receptor A antagonist | 0.03 0.003 DB13169 | DB13169 | |
| 0.116 | 0.117 | 0.352 | Insulin secretagoues | 0.203 0.034 DBMET03359 0.263 0.017 DBMET03361 0.352 0.008 DBMET03362 | DBMET03362 | |
| 0.147 | 0.148 | 0.359 | Platelet antagonist | 0.16 0.135 DBMET03358 0.194 0.105 DBMET03359 0.16 0.135 DBMET03360 0.326 0.045 DBMET03361 0.359 0.036 DBMET03362 | DBMET03362 | |
| 0.114 | 0.117 | 0.194 | Acetylcholine M1 receptor antagonist | 0.194 0.045 DBMET03358 0.166 0.061 DBMET03359 0.194 0.045 DBMET03360 | DBMET03360 | |
| 0.013 | 0.016 | 0.03 | Thromboxane A2 agonist | 0.015 0.012 DB13169 0.026 0.004 DBMET03358 0.03 0.003 DBMET03359 0.026 0.004 DBMET03360 | DBMET03359 | |
| 0.082 | 0.087 | 0.162 | Lanosterol 14 alpha demethylase inhibitor | 0.089 0.074 DB13169 0.132 0.021 DBMET03358 0.162 0.008 DBMET03359 0.132 0.021 DBMET03360 | DBMET03359 | |
| 0.008 | 0.014 | 0.021 | Thromboxane agonist | 0.017 0.004 DBMET03358 0.021 0.004 DBMET03359 0.017 0.004 DBMET03360 | DBMET03359 | |
| 0.093 | 0.099 | 0.133 | Acetylcholine muscarinic antagonist | 0.127 0.06 DBMET03358 0.133 0.055 DBMET03359 0.127 0.06 DBMET03360 | DBMET03359 | |
| 0.084 | 0.09 | 0.447 | Expectorant | 0.103 0.065 DB13169 0.142 0.039 DBMET03358 0.198 0.021 DBMET03359 0.142 0.039 DBMET03360 0.325 0.007 DBMET03361 0.447 0.004 DBMET03362 | DBMET03362 | |
| 0.028 | 0.037 | 0.054 | Estrogen-related receptor beta antagonist | 0.054 0.005 DB13169 0.051 0.005 DBMET03359 | DB13169 | |
| 0.147 | 0.157 | 0.334 | Cyclic AMP phosphodiesterase inhibitor | 0.156 0.142 DB13169 0.219 0.081 DBMET03358 0.209 0.087 DBMET03359 0.219 0.081 DBMET03360 0.334 0.03 DBMET03361 0.329 0.032 DBMET03362 | DBMET03361 | |
| 0.04 | 0.05 | 0.084 | Parathyroid hormone antagonist | 0.05 0.022 DB13169 0.072 0.006 DBMET03358 0.084 0.004 DBMET03359 0.072 0.006 DBMET03360 | DBMET03359 | |
| 0.023 | 0.036 | 0.03 | Prostaglandin agonist | 0.03 0.022 DBMET03358 0.03 0.022 DBMET03360 | DBMET03360 | |
| 0.001 | 0.015 | 0.004 | Vitamin D-like | 0.004 0.003 DBMET03359 | DBMET03359 | |
| 0.058 | 0.073 | 0.088 | Glutamate (mGluR6) antagonist | 0.064 0.054 DB13169 0.081 0.023 DBMET03358 0.088 0.017 DBMET03359 0.081 0.023 DBMET03360 | DBMET03359 | |
| 0.02 | 0.035 | 0.042 | Vanilloid 2 agonist | 0.026 0.015 DBMET03359 0.037 0.005 DBMET03361 0.042 0.004 DBMET03362 | DBMET03362 | |
| 0.146 | 0.163 | 0.389 | Vasodilator | 0.237 0.077 DBMET03358 0.228 0.083 DBMET03359 0.237 0.077 DBMET03360 0.385 0.026 DBMET03361 0.389 0.025 DBMET03362 | DBMET03362 | |
| 0.028 | 0.046 | 0.059 | Tubulin agonist | 0.044 0.011 DB13169 0.052 0.007 DBMET03358 0.059 0.005 DBMET03359 0.052 0.007 DBMET03360 0.036 0.02 DBMET03361 0.038 0.017 DBMET03362 | DBMET03359 | |
| 0.084 | 0.105 | 0.184 | Mucolytic | 0.105 0.071 DB13169 0.144 0.036 DBMET03358 0.18 0.019 DBMET03359 0.144 0.036 DBMET03360 0.145 0.035 DBMET03361 0.184 0.018 DBMET03362 | DBMET03362 | |
| 0.008 | 0.031 | 0.03 | Prostacyclin agonist | 0.02 0.008 DBMET03358 0.03 0.006 DBMET03359 0.02 0.008 DBMET03360 | DBMET03359 | |
| 0.09 | 0.113 | 0.126 | Acetylcholine release stimulant | 0.101 0.086 DBMET03359 0.111 0.063 DBMET03361 0.126 0.04 DBMET03362 | DBMET03362 | |
| 0.03 | 0.053 | 0.055 | Opioid kappa receptor agonist | 0.055 0.021 DBMET03358 0.044 0.029 DBMET03359 0.055 0.021 DBMET03360 | DBMET03360 | |
| 0.129 | 0.157 | 0.144 | Succinate dehydrogenase inhibitor | 0.14 0.132 DBMET03358 0.144 0.125 DBMET03359 0.14 0.132 DBMET03360 | DBMET03359 | |
| 0.004 | 0.032 | 0.02 | Antibiotic Macrolide-like | 0.019 0.007 DBMET03361 0.02 0.007 DBMET03362 | DBMET03362 | |
| 0.027 | 0.055 | 0.06 | 2,3-Oxidosqualene-lanosterol cyclase inhibitor | 0.06 0.007 DBMET03358 0.049 0.012 DBMET03359 0.06 0.007 DBMET03360 | DBMET03360 | |
| 0.021 | 0.05 | 0.032 | 1,3-Beta-glucan synthase inhibitor | 0.026 0.025 DBMET03359 0.03 0.015 DBMET03361 0.032 0.011 DBMET03362 | DBMET03362 | |
| 0.036 | 0.069 | 0.073 | Glucose-6-phosphate isomerase inhibitor | 0.055 0.023 DBMET03358 0.062 0.017 DBMET03359 0.055 0.023 DBMET03360 0.063 0.016 DBMET03361 0.073 0.011 DBMET03362 | DBMET03362 | |
| 0.04 | 0.078 | 0.265 | Heparanase inhibitor | 0.057 0.029 DBMET03358 0.064 0.018 DBMET03359 0.057 0.029 DBMET03360 0.213 0.002 DBMET03361 0.265 0.002 DBMET03362 | DBMET03362 | |
| 0.044 | 0.083 | 0.07 | Lipase inhibitor | 0.07 0.054 DBMET03358 0.07 0.054 DBMET03360 0.063 0.061 DBMET03361 | DBMET03360 | |
| 0.169 | 0.21 | 0.299 | Angiogenesis inhibitor | 0.24 0.131 DB13169 0.196 0.174 DBMET03359 0.196 0.174 DBMET03361 0.299 0.093 DBMET03362 | DBMET03362 | |
| 0.051 | 0.095 | 0.084 | Epoxide hydrolase inhibitor | 0.084 0.038 DBMET03359 | DBMET03359 | |
| 0.034 | 0.079 | 0.288 | GABA receptor antagonist | 0.288 0.004 DBMET03358 0.18 0.007 DBMET03359 0.288 0.004 DBMET03360 | DBMET03360 | |
| 0.033 | 0.082 | 0.244 | GABA A receptor antagonist | 0.244 0.005 DBMET03358 0.156 0.008 DBMET03359 0.244 0.005 DBMET03360 | DBMET03360 | |
| 0.057 | 0.109 | 0.079 | Opioid kappa receptor antagonist | 0.079 0.059 DBMET03358 0.079 0.059 DBMET03360 | DBMET03360 | |
| 0.022 | 0.075 | 0.033 | Carboxypeptidase B inhibitor | 0.033 0.022 DBMET03359 | DBMET03359 | |
| 0.039 | 0.092 | 0.093 | Botulinum neurotoxin type A inhibitor | 0.052 0.051 DB13169 0.074 0.021 DBMET03358 0.093 0.011 DBMET03359 0.074 0.021 DBMET03360 | DBMET03359 | |
| 0.022 | 0.077 | 0.16 | 11-Beta-hydroxysteroid dehydrogenase 1 inhibitor | 0.061 0.022 DB13169 0.134 0.007 DBMET03358 0.16 0.005 DBMET03359 0.134 0.007 DBMET03360 | DBMET03359 | |
| 0.006 | 0.061 | 0.027 | NMDA receptor phencyclidine site antagonist | 0.02 0.007 DBMET03358 0.027 0.005 DBMET03359 0.02 0.007 DBMET03360 | DBMET03359 | |
| 0.036 | 0.091 | 0.073 | Glucose-6-phosphate translocase inhibitor | 0.068 0.017 DBMET03361 0.073 0.014 DBMET03362 | DBMET03362 | |
| 0.017 | 0.073 | 0.045 | Estrogen-related receptor alpha antagonist | 0.045 0.015 DB13169 0.043 0.016 DBMET03359 | DB13169 | |
| 0.037 | 0.094 | 0.193 | Phosphofructokinase-1 inhibitor | 0.087 0.038 DBMET03358 0.101 0.031 DBMET03359 0.087 0.038 DBMET03360 0.169 0.015 DBMET03361 0.193 0.012 DBMET03362 | DBMET03362 | |
| 0.012 | 0.078 | 0.032 | CYP24 inhibitor | 0.021 0.018 DB13169 0.028 0.011 DBMET03358 0.032 0.009 DBMET03359 0.028 0.011 DBMET03360 | DBMET03359 | |
| 0.063 | 0.13 | 0.106 | ATPase (Vacuolar H+) inhibitor | 0.105 0.033 DBMET03361 0.106 0.032 DBMET03362 | DBMET03362 | |
| 0.073 | 0.143 | 0.121 | Adenylate kinase inhibitor | 0.108 0.056 DBMET03358 0.121 0.043 DBMET03359 0.108 0.056 DBMET03360 | DBMET03359 | |
| 0.041 | 0.112 | 0.059 | Adenine nucleotide translocase inhibitor | 0.055 0.039 DBMET03361 0.059 0.031 DBMET03362 | DBMET03362 | |
| 0.028 | 0.102 | 0.074 | Argininosuccinate synthase inhibitor | 0.074 0.028 DBMET03358 0.053 0.043 DBMET03359 0.074 0.028 DBMET03360 | DBMET03360 | |
| 0.02 | 0.096 | 0.055 | GABA uptake inhibitor | 0.035 0.034 DB13169 0.04 0.026 DBMET03358 0.055 0.012 DBMET03359 0.04 0.026 DBMET03360 | DBMET03359 | |
| 0.051 | 0.127 | 0.105 | Carbonic anhydrase VI inhibitor | 0.105 0.036 DBMET03358 0.105 0.036 DBMET03360 0.084 0.053 DBMET03361 | DBMET03360 | |
| 0.153 | 0.23 | 0.496 | Immunomodulator | 0.277 0.096 DBMET03358 0.303 0.08 DBMET03359 0.277 0.096 DBMET03360 0.471 0.028 DBMET03361 0.496 0.024 DBMET03362 | DBMET03362 | |
| 0.028 | 0.107 | 0.056 | Cholesterol esterase inhibitor | 0.056 0.021 DBMET03359 | DBMET03359 | |
| 0.065 | 0.145 | 0.079 | Hematopoietic | 0.079 0.076 DBMET03359 | DBMET03359 | |
| 0.012 | 0.092 | 0.073 | Protein 30S ribosomal subunit inhibitor | 0.071 0.005 DBMET03361 0.073 0.004 DBMET03362 | DBMET03362 | |
| 0.021 | 0.105 | 0.093 | Liver X receptor alpha agonist | 0.055 0.016 DB13169 0.062 0.012 DBMET03358 0.093 0.005 DBMET03359 0.062 0.012 DBMET03360 | DBMET03359 | |
| 0.058 | 0.148 | 0.133 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.094 0.061 DBMET03358 0.117 0.041 DBMET03359 0.094 0.061 DBMET03360 0.102 0.052 DBMET03361 0.133 0.032 DBMET03362 | DBMET03362 | |
| 0.025 | 0.116 | 0.055 | Acetylcholine M2 receptor agonist | 0.055 0.035 DBMET03359 | DBMET03359 | |
| 0.05 | 0.142 | 0.197 | Topoisomerase I inhibitor | 0.191 0.029 DBMET03361 0.197 0.027 DBMET03362 | DBMET03362 | |
| 0.04 | 0.134 | 0.138 | Topoisomerase II alpha inhibitor | 0.135 0.026 DBMET03361 0.138 0.025 DBMET03362 | DBMET03362 | |
| 0.192 | 0.287 | 0.804 | Cyclophilin D inhibitor | 0.274 0.187 DB13169 0.423 0.078 DBMET03358 0.534 0.041 DBMET03359 0.423 0.078 DBMET03360 0.76 0.009 DBMET03361 0.804 0.006 DBMET03362 | DBMET03362 | |
| 0.066 | 0.162 | 0.118 | Glutamate release inhibitor | 0.084 0.077 DBMET03358 0.095 0.051 DBMET03359 0.084 0.077 DBMET03360 0.105 0.035 DBMET03361 0.118 0.023 DBMET03362 | DBMET03362 | |
| 0.019 | 0.122 | 0.034 | Glutamate (mGluR3) agonist | 0.031 0.026 DBMET03358 0.034 0.019 DBMET03359 0.031 0.026 DBMET03360 | DBMET03359 | |
| 0.023 | 0.13 | 0.174 | Alcohol oxidase inhibitor | 0.069 0.03 DB13169 0.174 0.008 DBMET03358 0.115 0.015 DBMET03359 0.174 0.008 DBMET03360 | DBMET03360 | |
| 0.144 | 0.251 | 0.446 | Vasodilator, coronary | 0.276 0.109 DBMET03358 0.319 0.073 DBMET03359 0.276 0.109 DBMET03360 0.393 0.037 DBMET03361 0.446 0.024 DBMET03362 | DBMET03362 | |
| 0.118 | 0.227 | 0.492 | Cardiotonic | 0.185 0.134 DB13169 0.459 0.02 DBMET03358 0.492 0.016 DBMET03359 0.459 0.02 DBMET03360 0.293 0.059 DBMET03361 0.295 0.058 DBMET03362 | DBMET03359 | |
| 0.025 | 0.136 | 0.049 | GABA B receptor antagonist | 0.045 0.026 DBMET03358 0.049 0.02 DBMET03359 0.045 0.026 DBMET03360 | DBMET03359 | |
| 0.019 | 0.133 | 0.071 | Liver X receptor agonist | 0.047 0.025 DBMET03358 0.071 0.013 DBMET03359 0.047 0.025 DBMET03360 | DBMET03359 | |
| 0.036 | 0.151 | 0.125 | Phospholipase D inhibitor | 0.088 0.024 DBMET03358 0.125 0.005 DBMET03359 0.088 0.024 DBMET03360 | DBMET03359 | |
| 0.084 | 0.201 | 0.155 | Sigma receptor agonist | 0.155 0.082 DB13169 | DB13169 | |
| 0.022 | 0.141 | 0.041 | Thymidine kinase inhibitor | 0.041 0.028 DBMET03359 | DBMET03359 | |
| 0.024 | 0.146 | 0.124 | Alpha-mannosidase inhibitor | 0.062 0.024 DBMET03358 0.077 0.013 DBMET03359 0.062 0.024 DBMET03360 0.094 0.007 DBMET03361 0.124 0.004 DBMET03362 | DBMET03362 | |
| 0.06 | 0.182 | 0.139 | Multidrug resistance-associated protein 1 inhibitor | 0.137 0.033 DBMET03361 0.139 0.031 DBMET03362 | DBMET03362 | |
| 0.021 | 0.142 | 0.064 | Acyl-CoA dehydrogenase inhibitor | 0.064 0.03 DBMET03359 | DBMET03359 | |
| 0.005 | 0.131 | 0.061 | Arginase inhibitor | 0.038 0.024 DBMET03359 0.051 0.014 DBMET03361 0.061 0.01 DBMET03362 | DBMET03362 | |
| 0.029 | 0.161 | 0.072 | Neuraminidase (influenza) inhibitor | 0.066 0.041 DBMET03361 0.072 0.033 DBMET03362 | DBMET03362 | |
| 0.03 | 0.162 | 0.071 | Sphingosine kinase inhibitor | 0.057 0.045 DBMET03358 0.071 0.024 DBMET03359 0.057 0.045 DBMET03360 | DBMET03359 | |
| 0.052 | 0.188 | 0.194 | GABA receptor agonist | 0.194 0.019 DBMET03358 0.16 0.031 DBMET03359 0.194 0.019 DBMET03360 | DBMET03360 | |
| 0.046 | 0.183 | 0.106 | Creatine kinase inhibitor | 0.106 0.053 DB13169 0.091 0.07 DBMET03358 0.091 0.07 DBMET03360 | DB13169 | |
| 0.085 | 0.225 | 0.453 | Hemostatic | 0.146 0.073 DBMET03358 0.138 0.083 DBMET03359 0.146 0.073 DBMET03360 0.453 0.005 DBMET03361 0.441 0.005 DBMET03362 | DBMET03361 | |
| 0.149 | 0.289 | 0.46 | Histamine release inhibitor | 0.456 0.047 DBMET03361 0.46 0.045 DBMET03362 | DBMET03362 | |
| 0.036 | 0.176 | 0.09 | Acetylcholine M3 receptor agonist | 0.09 0.052 DBMET03359 | DBMET03359 | |
| 0.015 | 0.16 | 0.055 | Ceramide glucosyltransferase inhibitor | 0.041 0.016 DBMET03358 0.055 0.005 DBMET03359 0.041 0.016 DBMET03360 0.044 0.012 DBMET03362 | DBMET03359 | |
| 0.042 | 0.188 | 0.155 | GABA A receptor agonist | 0.155 0.015 DBMET03358 0.119 0.024 DBMET03359 0.155 0.015 DBMET03360 | DBMET03360 | |
| 0.016 | 0.162 | 0.107 | Mannosidase inhibitor | 0.044 0.034 DBMET03358 0.059 0.018 DBMET03359 0.044 0.034 DBMET03360 0.079 0.009 DBMET03361 0.107 0.005 DBMET03362 | DBMET03362 | |
| 0.021 | 0.168 | 0.356 | Selectin antagonist | 0.331 0.004 DBMET03361 0.356 0.004 DBMET03362 | DBMET03362 | |
| 0.14 | 0.291 | 0.482 | Antiobesity | 0.408 0.063 DBMET03358 0.482 0.041 DBMET03359 0.408 0.063 DBMET03360 0.432 0.054 DBMET03361 0.47 0.044 DBMET03362 | DBMET03359 | |
| 0.022 | 0.173 | 0.04 | Kainate receptor agonist | 0.04 0.032 DBMET03359 | DBMET03359 | |
| 0.018 | 0.171 | 0.045 | Neuraminidase (Influenza A) inhibitor | 0.042 0.038 DBMET03361 0.045 0.033 DBMET03362 | DBMET03362 | |
| 0.007 | 0.16 | 0.067 | Carbonic anhydrase IV inhibitor | 0.067 0.016 DBMET03358 0.059 0.02 DBMET03359 0.067 0.016 DBMET03360 | DBMET03360 | |
| 0.013 | 0.167 | 0.059 | Acetylcholine muscarinic agonist | 0.05 0.043 DBMET03358 0.059 0.035 DBMET03359 0.05 0.043 DBMET03360 | DBMET03359 | |
| 0.01 | 0.165 | 0.03 | Liver X receptor beta agonist | 0.03 0.029 DBMET03359 | DBMET03359 | |
| 0.015 | 0.173 | 0.028 | Thymidine kinase (Herpes simplex virus 1) inhibitor | 0.025 0.022 DB13169 0.026 0.021 DBMET03358 0.028 0.015 DBMET03359 0.026 0.021 DBMET03360 | DBMET03359 | |
| 0.008 | 0.167 | 0.028 | Antibiotic Anthracycline-like | 0.028 0.004 DBMET03361 0.025 0.005 DBMET03362 | DBMET03361 | |
| 0.089 | 0.249 | 0.17 | CF transmembrane conductance regulator agonist | 0.134 0.109 DB13169 0.137 0.101 DBMET03358 0.17 0.046 DBMET03359 0.137 0.101 DBMET03360 0.134 0.109 DBMET03362 | DBMET03359 | |
| 0.097 | 0.258 | 0.291 | ATPase inhibitor | 0.17 0.071 DBMET03358 0.182 0.055 DBMET03359 0.17 0.071 DBMET03360 0.276 0.009 DBMET03361 0.291 0.007 DBMET03362 | DBMET03362 | |
| 0.01 | 0.174 | 0.045 | Geranyltranstransferase inhibitor | 0.045 0.029 DBMET03359 | DBMET03359 | |
| 0.043 | 0.218 | 0.248 | UDP-glucose 4-epimerase inhibitor | 0.11 0.051 DB13169 0.143 0.031 DBMET03358 0.116 0.046 DBMET03359 0.143 0.031 DBMET03360 0.248 0.013 DBMET03361 0.2 0.018 DBMET03362 | DBMET03361 | |
| 0.044 | 0.228 | 0.138 | Triose-phosphate isomerase inhibitor | 0.092 0.056 DBMET03358 0.094 0.055 DBMET03359 0.092 0.056 DBMET03360 0.13 0.027 DBMET03361 0.138 0.024 DBMET03362 | DBMET03362 | |
| 0.034 | 0.218 | 0.071 | Glutamate dehydrogenase inhibitor | 0.071 0.055 DBMET03359 | DBMET03359 | |
| 0.015 | 0.199 | 0.058 | Neuraminidase inhibitor | 0.058 0.046 DBMET03362 | DBMET03362 | |
| 0.012 | 0.202 | 0.057 | NMDA 2C receptor antagonist | 0.057 0.05 DBMET03359 | DBMET03359 | |
| 0.038 | 0.229 | 0.21 | Topoisomerase II inhibitor | 0.21 0.031 DBMET03361 0.21 0.031 DBMET03362 | DBMET03362 | |
| 0.018 | 0.212 | 0.079 | Carbamoyl phosphate synthetase inhibitor | 0.061 0.042 DBMET03358 0.079 0.029 DBMET03359 0.061 0.042 DBMET03360 | DBMET03359 | |
| 0.017 | 0.219 | 0.048 | Diacylglycerol O-acyltransferase inhibitor | 0.048 0.039 DBMET03359 | DBMET03359 | |
| 0.017 | 0.22 | 0.088 | Antibiotic Aminoglycoside-like | 0.082 0.004 DBMET03361 0.088 0.004 DBMET03362 | DBMET03362 | |
| 0.098 | 0.304 | 0.162 | CC chemokine 6 receptor antagonist | 0.12 0.117 DBMET03359 0.156 0.016 DBMET03361 0.162 0.011 DBMET03362 | DBMET03362 | |
| 0.048 | 0.256 | 0.344 | Alpha-N-acetylglucosaminidase inhibitor | 0.14 0.061 DB13169 0.209 0.032 DBMET03358 0.287 0.018 DBMET03359 0.209 0.032 DBMET03360 0.24 0.025 DBMET03361 0.344 0.012 DBMET03362 | DBMET03362 | |
| 0.033 | 0.246 | 0.081 | Potassium channel activator | 0.081 0.074 DBMET03358 0.081 0.074 DBMET03360 | DBMET03360 | |
| 0.011 | 0.226 | 0.038 | Glutamate (mGluR3) antagonist | 0.033 0.031 DBMET03358 0.038 0.023 DBMET03359 0.033 0.031 DBMET03360 | DBMET03359 | |
| 0.008 | 0.236 | 0.051 | Guanylate cyclase inhibitor | 0.046 0.025 DBMET03359 0.039 0.036 DBMET03361 0.051 0.02 DBMET03362 | DBMET03362 | |
| 0.008 | 0.236 | 0.032 | Nicotinic acid receptor agonist | 0.032 0.03 DBMET03359 | DBMET03359 | |
| 0.038 | 0.27 | 0.104 | GABA C receptor antagonist | 0.104 0.072 DBMET03359 | DBMET03359 | |
| 0.05 | 0.289 | 0.24 | Cell adhesion inhibitor | 0.21 0.022 DBMET03361 0.24 0.016 DBMET03362 | DBMET03362 | |
| 0.034 | 0.282 | 0.114 | GABA C receptor agonist | 0.091 0.078 DBMET03358 0.114 0.054 DBMET03359 0.091 0.078 DBMET03360 | DBMET03359 | |
| 0.008 | 0.265 | 0.037 | Purinergic P2Y15 antagonist | 0.03 0.017 DBMET03358 0.037 0.009 DBMET03359 0.03 0.017 DBMET03360 | DBMET03359 | |
| 0.148 | 0.41 | 0.246 | 5 Hydroxytryptamine release inhibitor | 0.246 0.234 DBMET03362 | DBMET03362 | |
| 0.013 | 0.276 | 0.042 | Sphingosine kinase 1 inhibitor | 0.042 0.027 DBMET03359 | DBMET03359 | |
| 0.036 | 0.302 | 0.08 | GABA B receptor agonist | 0.073 0.06 DBMET03358 0.08 0.041 DBMET03359 0.073 0.06 DBMET03360 | DBMET03359 | |
| 0.007 | 0.277 | 0.072 | Phosphorylase inhibitor | 0.053 0.029 DBMET03359 0.072 0.019 DBMET03362 | DBMET03362 | |
| 0.005 | 0.301 | 0.053 | Sodium/glucose cotransporter 2 inhibitor | 0.042 0.008 DBMET03361 0.053 0.006 DBMET03362 | DBMET03362 | |
| 0.021 | 0.32 | 0.13 | M18 aspartyl aminopeptidase inhibitor | 0.13 0.063 DB13169 | DB13169 | |
| 0.035 | 0.36 | 0.138 | NADH dehydrogenase inhibitor | 0.087 0.061 DBMET03358 0.097 0.047 DBMET03359 0.087 0.061 DBMET03360 0.123 0.027 DBMET03361 0.138 0.021 DBMET03362 | DBMET03362 | |
| 0.034 | 0.367 | 0.125 | Beta amyloid protein antagonist | 0.125 0.062 DBMET03362 | DBMET03362 | |
| 0.005 | 0.343 | 0.043 | Sodium/glucose cotransporter inhibitor | 0.033 0.009 DBMET03361 0.043 0.006 DBMET03362 | DBMET03362 | |
| 0.014 | 0.365 | 0.063 | Sphingosine kinase 2 inhibitor | 0.063 0.028 DBMET03359 | DBMET03359 | |
| 0.097 | 0.453 | 0.418 | Peptidyltransferase inhibitor | 0.223 0.074 DBMET03358 0.231 0.066 DBMET03359 0.223 0.074 DBMET03360 0.404 0.007 DBMET03361 0.418 0.006 DBMET03362 | DBMET03362 | |
| 0.027 | 0.394 | 0.191 | Beta glucuronidase inhibitor | 0.092 0.083 DBMET03359 0.145 0.027 DBMET03361 0.191 0.014 DBMET03362 | DBMET03362 | |
| 0.004 | 0.404 | 0.062 | NMDA 2 receptor antagonist | 0.062 0.06 DBMET03359 | DBMET03359 | |
| 0.018 | 0.425 | 0.098 | Mediator release inhibitor | 0.098 0.072 DBMET03361 | DBMET03361 | |
| 0.01 | 0.434 | 0.055 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.055 0.04 DBMET03359 | DBMET03359 | |
| 0.024 | 0.525 | 0.083 | MAP kinase kinase 7 inhibitor | 0.078 0.053 DBMET03358 0.083 0.037 DBMET03359 0.078 0.053 DBMET03360 | DBMET03359 | |
| 0.035 | 0.549 | 0.177 | Hexokinase inhibitor | 0.177 0.052 DBMET03361 0.153 0.075 DBMET03362 | DBMET03361 | |
| 0.024 | 0.547 | 0.231 | Cell wall synthesis inhibitor | 0.177 0.042 DBMET03361 0.231 0.02 DBMET03362 | DBMET03362 | |
| 0.022 | 0.576 | 0.169 | Cyclin-dependent kinase 8 inhibitor | 0.125 0.11 DBMET03358 0.169 0.061 DBMET03359 0.125 0.11 DBMET03360 | DBMET03359 | |
| 0.101 | 0.657 | 0.287 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.287 0.23 DBMET03359 | DBMET03359 | |
| 0.036 | 0.607 | 0.157 | DNA repair enzyme inhibitor | 0.157 0.026 DBMET03361 0.113 0.089 DBMET03362 | DBMET03361 | |
| 0.011 | 0.654 | 0.085 | Uric acid excretion stimulant | 0.085 0.073 DBMET03361 0.084 0.075 DBMET03362 | DBMET03361 | |
| 0.004 | 0.724 | 0.025 | Motilin receptor agonist | 0.022 0.018 DBMET03361 0.025 0.013 DBMET03362 | DBMET03362 | |
| 0.008 | 0.756 | 0.205 | Anticoagulant | 0.168 0.067 DBMET03361 0.205 0.051 DBMET03362 | DBMET03362 | |
| 0.006 | 0.981 | 0.059 | Factor IXa inhibitor | 0.046 0.043 DBMET03361 0.059 0.028 DBMET03362 | DBMET03362 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |